FDA Approves Extra U.S. Manufacturing Capacity for Alvotech’s Humira Biosimilar SIMLANDI

FDA cleared a second Reykjavik suite for SIMLANDI, doubling U.S. drug-substance capacity and confirming earlier inspection issues are resolved.